Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chemicals, Inc
Citation | 85 FR 46730 |
Record Number | 2020-16775 |
Published date | 03 August 2020 |
Section | Notices |
Court | Drug Enforcement Administration,Justice Department |
Federal Register, Volume 85 Issue 149 (Monday, August 3, 2020)
[Federal Register Volume 85, Number 149 (Monday, August 3, 2020)] [Notices] [Pages 46730-46731] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2020-16775] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-692] Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chemicals, Inc ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 2, 2020. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on July 13, 2020, American Radiolabeled Chemicals, Inc, 101 Arc Drive Saint Louis, Missouri 63146-3502, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Gamma Hydroxybutyric Acid................ 2010 I Ibogaine................................. 7260 I Lysergic acid diethylamide............... 7315 I Tetrahydrocannabinols.................... 7370 I Dimethyltryptamine....................... 7435 I 1-[1-(2-Thienyl)cyclohexyl]piperidine.... 7470 I Dihydromorphine.......................... 9145 I Heroin................................... 9200 I Normorphine.............................. 9313 I Amphetamine.............................. 1100 II Methamphetamine.......................... 1105 II Amobarbital.............................. 2125 II Phencyclidine............................ 7471 II Phenylacetone............................ 8501 II Cocaine.................................. 9041 II Codeine.................................. 9050 II Dihydrocodeine........................... 9120 II Oxycodone................................ 9143 II Hydromorphone............................ 9150 II Ecgonine................................. 9180 II Hydrocodone.............................. 9193 II Meperidine............................... 9230 II Metazocine............................... 9240 II Methadone................................ 9250 II Dextropropoxyphene, bulk (non-dosage 9273 II forms). Morphine................................. 9300 II Oripavine................................ 9330 II Thebaine................................. 9333 II Oxymorphone.............................. 9652 II Phenazocine.............................. 9715 II Carfentanil.............................. 9743 II Fentanyl................................. 9801 II ------------------------------------------------------------------------ [[Page 46731]] The company plans to manufacture small quantities of the above- listed controlled substances as radiolabeled compounds for biochemical research. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020-16775 Filed 7-31-20; 8:45 am] BILLING CODE 4410-09-P